Joseph M. Rancour

Joe Rancour represents clients in connection with antitrust aspects of mergers and acquisitions and antitrust litigation. Mr. Rancour has experience across a variety of industries, including semiconductors and other high technology markets, telecommunications, medical devices, life sciences, chemicals, and financial exchanges.

Examples of Mr. Rancour’s M&A representations include:

• Sprint in its proposed merger with T-Mobile;
• CME Group in its acquisition of NEX;
• Intel in its acquisition of Mobileye, sale of Wind River to TPG and spin-out of the Intel Security business (McAfee);
• NXP in its proposed acquisition by Qualcomm;
• Cardinal Health in its acquisition of Medtronic’s Patient Care, Deep Vein Thrombosis and Nutritional Insufficiency businesses;
• Nokia in its acquisition of Alcatel-Lucent;
• Freescale in its acquisition by NXP;
• Merck KGaA in its acquisition of Sigma-Aldrich; and
• Corning in its acquisition of Becton Dickinson’s Discovery Labware.

Examples of Mr. Rancour’s litigation representations include:

• Sprint in its challenge to AT&T’s proposed acquisition of T-Mobile; and
• Norfolk Southern Railway Co. in a multi-defendant antitrust class action.

Mr. Rancour also has represented clients in pro bono matters, including Social Security disability and estate planning.